April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Erman Akkus: Nivolumab-ipilimumab vs SOC for non-clear cell RCC
Nov 11, 2024, 17:49

Erman Akkus: Nivolumab-ipilimumab vs SOC for non-clear cell RCC

Erman Akkus, Medical Oncology fellow at the Ankara University, shared a post on X:

Nivolumab-ipilimumab vs SOC for non-clear cell RCC.

SUNNIFORECAST trial, EMUC24

Met primary endpoint
12-month OS rate: 86.9% vs 76.8″

Erman Akkus: Nivolumab-ipilimumab vs SOC for non-clear cell RCC

More posts featuring Erman Akkus.

Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.